Immunoprecise Antibodies Ltd
XTSX:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
XTSX:IPA
Watchlist
Price: 6.5 CAD 0.78% Market Closed
Market Cap: CA$161.4m

Gross Margin

55%
Current
No historical data
Comparison unavailable

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
55%
=
Gross Profit
CA$10.5m
/
Revenue
CA$19m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
55%
=
Gross Profit
CA$10.5m
/
Revenue
CA$19m

Peer Comparison

Country Company Market Cap Gross
Margin
CA
Immunoprecise Antibodies Ltd
XTSX:IPA
161.4m CAD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Higher than 75% of companies in Canada
Percentile
75th
Based on 4 108 companies
75th percentile
55%
Low
-10 058.3% — 20.4%
Typical Range
20.4% — 50.5%
High
50.5% — 717.4%
Distribution Statistics
Canada
Min -10 058.3%
30th Percentile 20.4%
Median 33.6%
70th Percentile 50.5%
Max 717.4%

Immunoprecise Antibodies Ltd
Glance View

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The company is headquartered in Vancouver, British Columbia and currently employs 73 full-time employees. The firm is focused on offering species-agnostic advancements, such as the B cell Select single-cell interrogation technology, DeepDisplay custom phage libraries, as well as the Abthena bispecific program. Its geographical segments include United States of America, Canada and Europe. The Company’s Antibody Discovery offers design, immunization, characterization and optimization, and preclinical services. The firm offers mammalian protein expression and purification services as stand-alone or in combination after an antibody discovery project to produce the number of antibodies that need for further work. Its mammalian rPEx platform allows the production of all kinds of proteins, including difficult-to-express proteins, Fc-fusion proteins and bispecific antibodies.

IPA Intrinsic Value
Not Available
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
55%
=
Gross Profit
CA$10.5m
/
Revenue
CA$19m
How has Gross Margin changed over time?

Over the last 0 months, Immunoprecise Antibodies Ltd’s Gross Margin has decreased from 55% to 55%. During this period, it reached a low of 55% on Jan 31, 2022 and a high of 55% on Jan 31, 2022.

Back to Top